Research & Development Pipelines: Future of BTK Inhibitors
The BTK inhibitors pipeline is expanding, with next-generation therapies, novel drug combinations, and expanded indications set to drive market growth in the coming years. As R&D continues to progress, BTK inhibitors are expected to become an integral part of both cancer and autoimmune